Results 281 to 290 of about 3,864,754 (383)

A Reverse Transcriptase—Polymerase Chain Reaction Assay for the Diagnosis of Turkey Coronavirus Infection [PDF]

open access: hybrid, 2003
Binu T. Velayudhan   +5 more
openalex   +1 more source

The Antiviral Activity of Polyphenols

open access: yesMolecular Nutrition &Food Research, EarlyView.
Polyphenols demonstrate remarkable antiviral properties by effectively disrupting multiple biochemical processes essential for viral replication. ABSTRACT Polyphenols are secondary metabolites produced by a large variety of plants. These compounds that comprise the class of phenolic acids, stilbenes, lignans, coumarins, flavonoids, and tannins have a ...
Markus Burkard   +5 more
wiley   +1 more source

Colorimetric Reverse Transcription Loop-Mediated Isothermal Amplification with Xylenol Orange Targeting Nucleocapsid Gene for Detection of Feline Coronavirus Infection. [PDF]

open access: yesViruses
Khumtong K   +11 more
europepmc   +1 more source

Frequency of Guillain‐Barré Syndrome During the COVID‐19 Pandemic: A Multicenter Study

open access: yesMuscle &Nerve, EarlyView.
ABSTRACT Introduction/Aims The incidence of Guillain‐Barré syndrome (GBS) during the COVID‐19 pandemic varies according to country. We investigated the changes in the number of patients with GBS and their characteristics who were reported in Tokyo in 2020 at the beginning of the COVID‐19 pandemic, compared to those two years prior.
Toshiyuki Hayashi   +14 more
wiley   +1 more source

Diagnosis of canine coronavirus infection using nested-PCR

open access: bronze, 2000
Annamaria Pratelli   +5 more
openalex   +1 more source

A human in vitro model system for investigating genome-wide host responses to SARS coronavirus infection [PDF]

open access: gold, 2004
Lisa F. P. Ng   +10 more
openalex   +1 more source

Safety Extension Study of Edaravone Oral Suspension in Patients With Amyotrophic Lateral Sclerosis for up to an Additional 96 Weeks of Treatment

open access: yesMuscle &Nerve, EarlyView.
ABSTRACT Introduction/Aims Edaravone intravenous (IV) and oral suspension have been shown to have similar pharmacokinetics, safety, and slowing of functional decline in patients with amyotrophic lateral sclerosis (ALS). Study MT‐1186‐A01 indicated that edaravone oral suspension was well‐tolerated over 48 weeks, with no new safety concerns identified ...
Angela Genge   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy